Our mission is only one.
Patients and their families.
and
Improving the quality of life of medical staff .
"SparkBio is dedicated to improving the quality of life for patients and their families."
Through technology
We aim to comprehensively support the entire human life cycle, including prevention and early diagnosis at the pre-stage.
We discover promising, world-class (First in Class) Korean bio companies and create synergy through collaboration.
We also contribute to the development and spread of biotechnology through various funds and innovative investment strategies.
We are leading the way in changing the paradigm of the medical industry.
About
SparkLabs History
2012.12 - Establishment of Spark Lab Co., Ltd.
2012.12 - Sparklab Demo Day 1st held
2013.01 - Selected as a member of Global Accelerator Network (GAN)
2013 - A total of 1 new fund was created (Spark Lab Korea Fund No. 1, KRW 2.95 billion)
2016 - A total of 1 new fund was created (Spark Lab Korea Fund No. 2, KRW 11.4 billion)
2016.10 - SparkLabs IoT Accelerator launched
2017.04~09 - Sparklab Beijing, Sparklab Ventures, Sparklab Australia, Sparklab Taipei launched
2017.11 - Sparkchain Capital launched
2018.01 - SparkLabs Fintech launched
2018.06 - 11th Spark Lab Demo Day held (total of 2,500 attendees)
2018.12 - 12th Spark Lab Demo Day held (total of 2,300 attendees)
2019 - A total of 3 new fund creations (Sparklab Korea Fund No. 3, KRW 6.31 billion, Sparklab Discovery No. 1, KRW 2.4 billion, No. 2, KRW 1.5 billion)
2019.02 - SparkLabs Oman, Washington DC, SparkLabs Foundry launched
2019.06 - 13th Spark Lab Demo Day held (total of 2,700 attendees)
2019.08 - Establishment of Sparklab Korea's 3rd venture-specialized private equity joint venture
2019.08 - Creation of accelerator investment resources (fund)
2019.10 - Accelerator registration (Ministry of SMEs and Startups)
2019.12 - 14th Spark Lab Demo Day held (total of 2,400 attendees)
2020.04 - A total of 3 new funds were created (Discovery No. 3 KRW 1.06 billion, Sparklab-Shinhan Fund KRW 10.1 billion, RNP-Sparklab Cosmetic No. 1 KRW 12.5 billion)
2020.11 - 15th Spark Lab Demo Day held (2,200 people participated online)
2021.01 - A total of 1 new fund was created (Sparklab Cloud Fund 12.5 billion won)
2021.04 - 16th Spark Lab Demo Day held (total of 2,300 participants)
2021.06 - A total of 1 new fund was created (CJ CheilJedang Fund 1 billion won)
2021.07 - Sparklab Partners VC (Venture Capitalist) Registration
2021.09 - A total of 1 new fund was created (Sparklab Accelerator No. 4, KRW 2 billion)
2021.11 - 17th Spark Lab Demo Day held (total of 2,300 participants)
2022.03 - A total of 1 additional investment in existing funds (Sparklab Accelerator No. 4, KRW 8.3 billion)
2022.04 - A total of 1 new mother fund was created (Sparklab Tech First Step, KRW 9.1 billion)
2022.04 - 18th Spark Lab Demo Day held (total cumulative online views: approximately 9,000)
2022.11 - 19th Spark Lab Demo Day Offline Held (COEX, Total Visitors: Approximately 4,000)
2023.04 - Sparklab Open House 1st held (Maru 180, 180 applicants or so)
2023.04 - 20th Spark Lab Demo Day Offline Held (COEX, Total Visitors: Approximately 2,500)
2023.10 - Selection of participating companies for the UAE Economic Mission and participation in the tour
2023.10 - SparkLabs Group, Spark Acquisition (SPAC) listed on NASDAQ, USA
2023.10 - SparkLabs UAE Accelerator Launch
About
Clicking on the arrow will skip the corresponding content.
to
Why did SparkLabs launch SparkBio?
1. Special characteristics of life science and bio industry
Unlike general startups, the bio industry requires numerous regulations, high entry barriers, long market entry periods, and complex verification processes. SparkLabs' existing acceleration model was excellent in the IT, service, and platform fields, but it had limitations in effectively responding to the industrial complexity and regulatory environment unique to the bio industry. As a result, SparkBio, a bio-specialized accelerator with sector-specific expertise and networks, was born.
2. SparkBio’s 5 Core Support Elements
① Academic research and open innovation
Biotech companies need high-quality academic research support and sufficient research funding.
Additionally, it is essential to develop innovative technologies and conduct validation studies through close collaboration with academia, research institutes, and medical institutions.
② Skilled technical personnel
The growth of biotech companies requires the support of skilled professionals with extensive experience in the life sciences and technology industries.
From R&D to commercialization, expert mentoring and technical support are key elements for enhancing corporate competitiveness.
③ Fostering technology-based entrepreneurs
Biotech startups need strategic advice and business model development from experienced technology entrepreneurs to enter the market and scale their businesses.
This enables you to develop and execute effective growth strategies in a rapidly changing market.
④ Initial capital investment
Biotech startups need bold funding in their high-risk early stages.
Stable funding through SparkBio Fund provides a foundation for companies to focus on **research and development (R&D)** and market entry.
⑤ Specialized research infrastructure and experimental facilities
State-of-the-art research equipment and specialized research facilities are essential for biotech companies.
Mediopenlab provides cutting-edge experimental space and advanced research infrastructure at a reasonable cost, supporting efficient research and development for companies.
Source: Excerpt from Sparkbio proposal
Business Areas 01
Shared
Lab
Korea Health Management Association and SparkLabs meet.
Build your foundation with health data, accelerate with acceleration.
"Just focus on your research"
“Mediopenlab will help you with the rest.”
ABOUT
MEDI OPEN LAB
This is a shared laboratory office jointly created by global accelerator Sparklab and Korea Health Management Association, the No. 1 screening agency in Korea, to commercialize domestic bio startups with innovative technologies. It has a state-of-the-art research laboratory.
Join us at Mediopenlab at the forefront of innovation, from empirical research to product development.
Korea Health Management Association
17 million
Health checkup data
Mediopenlab
3 billion won
High-end equipment laboratory
SparkLabs
Sparkbio
Corporate investment and
Network Support
WHAT'S IN
MEDI OPEN LAB
Value
Based on health data !
Add acceleration with accelerating .
B
Biotechnology-Driven Innovation
Accelerate research and development in the bio industry based on over 17 million national health checkup data.
I
Impactful Collaboration
Our strategic partnership with SparkLabs provides you with a global network and investment opportunities.
O
Opportunities for Sustainable Growth
We minimize cost and resource constraints and support startups and SMEs to pursue sustainable innovation.
Introduction to the Korea Health Management Association
The Korea Health Management Association was established in 1964 and has been carrying out various projects with the goal of promoting healthy lives and welfare of the people. The association initially focused on preventing and eradicating parasitic diseases, but over time, its role has expanded widely.
In the early days of its establishment, it laid the foundation by establishing branches nationwide and promulgating the parasitic disease prevention method. Since then, it has carried out various health promotion projects domestically and internationally, and achieved important milestones including the establishment of a medical image information system, joining the WHO Health Promotion Hospital, and opening a parasite museum.
The association has an organizational structure that includes 16 branches across the country, and continues to operate efficiently through various departments such as the Planning and Coordination Headquarters, Operation Management Headquarters, Strategic Business Headquarters, Screening Management Headquarters, and Customer Management Headquarters. In addition, it operates specialized research and testing institutions such as the Medicheck Research Institute and the Central Testing Headquarters. In particular, the Parasite Museum was established to inform the public of the importance of preventing parasitic diseases and to provide a place for health education for the public.
The museum displays various testing equipment, medicines, promotional materials, and parasite specimens used to eradicate parasites, providing information to visitors. The history and activities of the Korea Health Management Association are evidence of the continuous efforts to promote national health. In addition to its role as a health screening center, the association contributes to improving the quality of life of the people as a central organization providing health-related information and research.
DISCOBER
MEDI OPEN LAB
Business Areas 02
Investment
Fund
SparkBio Fund creates value beyond investments.
SparkBio Investment Funds invests in biotechnology and healthcare.
We discover and support companies with leading technology and vision.
Each fund is designed with expertise focused on cutting-edge biotechnology and healthcare innovation.
We help companies create new opportunities for growth through global networking and strategic mentoring.
SparkBio Fund aims to go beyond simple investment and open up new possibilities in the healthcare industry through sustainable growth.
First Step Technology Fund
(Tech First Step Fund)
'Technology Company First Step Fund' is a tech-focused venture fund established to support the growth of excellent technology companies recommended by the Technology Guarantee Fund and early-stage startups without previous investment history.
The main investment targets are companies with a technology business evaluation rating of BBB or higher or excellent participants in the Kibo Venture Camp. It provides an environment where startups can focus on innovative technologies and ideas while reducing the financial burden on start-ups, and supports the rapid growth of startups through the SAFE (conditional equity acquisition agreement) method.
The 'Technology Company First Step Fund' provides a foundation for companies with innovative technologies to leap forward as unicorns in the global market and pursues sustainable growth in the startup ecosystem.
Saudi AI Fund
SAUDI AIM AI FUND
SPARKLABS AIM AI Fund is a $50 million global AI fund established in partnership with the Saudi Arabian government.
Established entirely with Saudi Arabian government funding, the fund supports the growth of innovative startups focused on artificial intelligence (AI) technologies and focuses on expanding the AI ecosystem in the Middle East and global markets.
In addition, SPARKLABS AIM AI Fund has already completed its first investment in a domestic bio company and has begun full-fledged steps to realize the fund's vision.
Through this, we plan to continue to provide support so that domestic and international startups can strengthen their competitiveness on the global stage.
Business Areas 03
Open Innovation
Inogeneics, Genecast, Xcube, PeopleBio, Sysmax, Bijouworks